These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 20506304

  • 1. Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis.
    Vuilleumier N, Bas S, Pagano S, Montecucco F, Guerne PA, Finckh A, Lovis C, Mach F, Hochstrasser D, Roux-Lombard P, Gabay C.
    Arthritis Rheum; 2010 Sep; 62(9):2640-50. PubMed ID: 20506304
    [Abstract] [Full Text] [Related]

  • 2. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
    Vuilleumier N, Charbonney E, Fontao L, Alvarez M, Turck N, Sanchez JC, Burkhard PR, Mensi N, Righini M, Reber G, James R, Mach F, Chevrolet JC, Dayer JM, Frostegard J, Roux-Lombard P.
    Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?
    Finckh A, Courvoisier DS, Pagano S, Bas S, Chevallier-Ruggeri P, Hochstrasser D, Roux-Lombard P, Gabay C, Vuilleumier N.
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):817-25. PubMed ID: 22302385
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy.
    Vuilleumier N, Montecucco F, Spinella G, Pagano S, Bertolotto M, Pane B, Pende A, Galan K, Roux-Lombard P, Combescure C, Dallegri F, Mach F, Palombo D.
    Thromb Haemost; 2013 Apr; 109(4):706-15. PubMed ID: 23364307
    [Abstract] [Full Text] [Related]

  • 5. Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus.
    O'Neill SG, Giles I, Lambrianides A, Manson J, D'Cruz D, Schrieber L, March LM, Latchman DS, Isenberg DA, Rahman A.
    Arthritis Rheum; 2010 Mar; 62(3):845-54. PubMed ID: 20131231
    [Abstract] [Full Text] [Related]

  • 6. Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity.
    Vuilleumier N, Bratt J, Alizadeh R, Jogestrand T, Hafström I, Frostegård J.
    Scand J Rheumatol; 2010 Nov; 39(6):447-53. PubMed ID: 20604674
    [Abstract] [Full Text] [Related]

  • 7. Anti-apolipoprotein A-1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis.
    Wick PA, Mombelli A, Pagano S, Moren X, Giannopoulou C, Mach F, Roux-Lombard P, Vuilleumier N.
    J Periodontal Res; 2013 Jun; 48(3):350-6. PubMed ID: 23050768
    [Abstract] [Full Text] [Related]

  • 8. Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction.
    Vuilleumier N, Rossier MF, Pagano S, Python M, Charbonney E, Nkoulou R, James R, Reber G, Mach F, Roux-Lombard P.
    Eur Heart J; 2010 Apr; 31(7):815-23. PubMed ID: 20176799
    [Abstract] [Full Text] [Related]

  • 9. Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability.
    Montecucco F, Vuilleumier N, Pagano S, Lenglet S, Bertolotto M, Braunersreuther V, Pelli G, Kovari E, Pane B, Spinella G, Pende A, Palombo D, Dallegri F, Mach F, Roux-Lombard P.
    Eur Heart J; 2011 Feb; 32(4):412-21. PubMed ID: 21224292
    [Abstract] [Full Text] [Related]

  • 10. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE, Schwartz GG, Olsson AG, Kinlay S, Szarek M, Rifai N, Libby P, Ganz P, Witztum JL, Tsimikas S, MIRACL Study Investigators.
    J Am Coll Cardiol; 2009 Jun 09; 53(23):2186-96. PubMed ID: 19497447
    [Abstract] [Full Text] [Related]

  • 11. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO, Fonseca FA, Fischer SM, Monteiro CM, Brandão SA, Póvoa RM, Bombig MT, Carvalho AC, Monteiro AM, Ramos E, Gidlund M, Figueiredo Neto AM, Izar MC.
    Clin Chim Acta; 2009 Aug 09; 406(1-2):113-8. PubMed ID: 19523463
    [Abstract] [Full Text] [Related]

  • 12. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis.
    Kim WU, Yoo WH, Park W, Kang YM, Kim SI, Park JH, Lee SS, Joo YS, Min JK, Hong YS, Lee SH, Park SH, Cho CS, Kim HY.
    J Rheumatol; 2000 Mar 09; 27(3):575-81. PubMed ID: 10743792
    [Abstract] [Full Text] [Related]

  • 13. High prevalence of anti-apolipoprotein/A-1 autoantibodies in maintenance hemodialysis and association with dialysis vintage.
    Pruijm M, Schmidtko J, Aho A, Pagano S, Roux-Lombard P, Teta D, Burnier M, Vuilleumier N.
    Ther Apher Dial; 2012 Dec 09; 16(6):588-94. PubMed ID: 23190520
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T, Shimada K, Ozawa N, Hayakawa H, Hagiwara F, Nakayama H, Sugii S, Ozawa Y, Tohma S.
    J Rheumatol; 2006 Dec 09; 33(12):2390-7. PubMed ID: 16924694
    [Abstract] [Full Text] [Related]

  • 15. Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex.
    Pagano S, Satta N, Werling D, Offord V, de Moerloose P, Charbonney E, Hochstrasser D, Roux-Lombard P, Vuilleumier N.
    J Intern Med; 2012 Oct 09; 272(4):344-57. PubMed ID: 22329401
    [Abstract] [Full Text] [Related]

  • 16. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G, Lambiri I, Nagel R, Keysser C, Keysser M, Gromnica-Ihle E, Franz J, Burmester GR, Jung K.
    J Rheumatol; 1999 Feb 09; 26(2):251-8. PubMed ID: 9972954
    [Abstract] [Full Text] [Related]

  • 17. [Anti-lipoprotein autoantibodies with hypolipidemia in infectious rheumatism].
    Noseda G.
    Schweiz Med Wochenschr; 1975 Feb 09; 105(31 Suppl):1-58. PubMed ID: 168637
    [Abstract] [Full Text] [Related]

  • 18. Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles.
    Yoo WH.
    J Rheumatol; 2004 Sep 09; 31(9):1746-53. PubMed ID: 15338494
    [Abstract] [Full Text] [Related]

  • 19. Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study.
    Benn M, Nordestgaard BG, Jensen GB, Tybjaerg-Hansen A.
    Arterioscler Thromb Vasc Biol; 2007 Mar 09; 27(3):661-70. PubMed ID: 17170368
    [Abstract] [Full Text] [Related]

  • 20. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors.
    Jørgensen KT, Wiik A, Pedersen M, Hedegaard CJ, Vestergaard BF, Gislefoss RE, Kvien TK, Wohlfahrt J, Bendtzen K, Frisch M.
    Ann Rheum Dis; 2008 Jun 09; 67(6):860-6. PubMed ID: 17644543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.